| Dr Douglas R Debenham, MD | |
|
3699 Epworth Rd, Newburgh, IN 47630-8909 | |
| (812) 471-1200 | |
| Not Available |
| Full Name | Dr Douglas R Debenham |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 30 Years |
| Location | 3699 Epworth Rd, Newburgh, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821056425 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Hospital | Vincennes, IN | Hospital |
| Fairbanks Memorial Hospital | Fairbanks, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Las Vegas Urology Llp | 5294713335 | 36 |
News Archive
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced that it received a patent for a laparoscopic electrosurgical electrical leakage detection device.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
Ion Torrent today announced that it is extending its Ion PGM Sequencer Grant Program to Europe, and will award two sequencers to scientists there in the second half of 2010. This spring Ion Torrent received hundreds of grant proposals from scientists in North America, and in April two winners were each awarded an Ion PGM sequencer.
Within three years, insulin-producing islet cells from pigs may be used in clinical trials on a path to finally cure insulin dependant diabetes.
› Verified 1 days ago
| Entity Name | Las Vegas Urology Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629054994 PECOS PAC ID: 5294713335 Enrollment ID: O20040713001361 |
News Archive
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced that it received a patent for a laparoscopic electrosurgical electrical leakage detection device.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
Ion Torrent today announced that it is extending its Ion PGM Sequencer Grant Program to Europe, and will award two sequencers to scientists there in the second half of 2010. This spring Ion Torrent received hundreds of grant proposals from scientists in North America, and in April two winners were each awarded an Ion PGM sequencer.
Within three years, insulin-producing islet cells from pigs may be used in clinical trials on a path to finally cure insulin dependant diabetes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas R Debenham, MD 11017 Cherwell Ct, Las Vegas, NV 89144-4526 Ph: (907) 280-8724 | Dr Douglas R Debenham, MD 3699 Epworth Rd, Newburgh, IN 47630-8909 Ph: (812) 471-1200 |
News Archive
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced that it received a patent for a laparoscopic electrosurgical electrical leakage detection device.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
Ion Torrent today announced that it is extending its Ion PGM Sequencer Grant Program to Europe, and will award two sequencers to scientists there in the second half of 2010. This spring Ion Torrent received hundreds of grant proposals from scientists in North America, and in April two winners were each awarded an Ion PGM sequencer.
Within three years, insulin-producing islet cells from pigs may be used in clinical trials on a path to finally cure insulin dependant diabetes.
› Verified 1 days ago
Steven G Becker, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4799 Rosebud Ln, Newburgh, IN 47630 Phone: 812-471-1591 Fax: 812-471-6650 | |
Dr. Michael J Miller, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3699 Epworth Rd, Newburgh, IN 47630 Phone: 812-471-1200 Fax: 812-475-6700 | |
Sanjiv Makhecha, D.O. Radiology Medicare: Medicare Enrolled Practice Location: 4799 Rosebud Ln, Newburgh, IN 47630 Phone: 812-471-1591 Fax: 812-471-6650 | |
Kathryn A Bryan, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 100 St Marys Epworth Xing, Ste. A500, Newburgh, IN 47630 Phone: 812-485-4437 Fax: 812-485-6890 |